1.Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
2.Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2) [published correction appears in Lancet. 2015 Mar 14;385(9972):946]. Lancet. 2015;385(9972):977–1010. doi:10.1016/S0140-6736(14)62038-9
3.Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: prevention, screening and early diagnosis. World J Gastroenterol. 2014;20(38):13842‐13862. doi:10.3748/wjg.v20.i38.13842
4.Roy RK, Hoppe MM, Srivastava S, et al. CEACAM6 is upregulated by Helicobacter pylori CagA and is a biomarker for early gastric cancer. Oncotarget. 2016;7(34):55290‐55301. doi:10.18632/oncotarget.10528
5.Qu S, Yang X, Li X, et al. Circular RNA: A new star of noncoding RNAs. Cancer Lett. 2015;365(2):141–148. doi:10.1016/j.canlet.2015.06.003
6.Qu S, Zhong Y, Shang R, et al. The emerging landscape of circular RNA in life processes. RNA Biol. 2017;14(8):992–999. doi:10.1080/15476286.2016.1220473
7.Pamudurti NR, Bartok O, Jens M, et al. Translation of CircRNAs. Mol Cell. 2017;66(1):9–21.e7. doi:10.1016/j.molcel.2017.02.021
8.Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One. 2012;7(2):e30733. doi:10.1371/journal.pone.0030733
9.Ashwal-Fluss R, Meyer M, Pamudurti NR, et al. circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56(1):55–66. doi:10.1016/j.molcel.2014.08.019
10.Shang Q, Yang Z, Jia R, Ge S. The novel roles of circRNAs in human cancer. Mol Cancer. 2019;18(1):6. Published 2019 Jan 9. doi:10.1186/s12943-018-0934-6
11.Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats [published correction appears in RNA. 2013 Mar;19(3):426]. RNA. 2013;19(2):141–157. doi:10.1261/rna.035667.112
12.Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388. doi:10.1038/nature11993
13.Yang R, Xing L, Zheng X, Sun Y, Wang X, Chen J. The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Mol Cancer. 2019;18(1):4. Published 2019 Jan 8. doi:10.1186/s12943-018-0933-7
14.Zheng F, Wang M, Li Y, et al. CircNR3C1 inhibits proliferation of bladder cancer cells by sponging miR-27a-3p and downregulating cyclin D1 expression. Cancer Lett. 2019;460:139‐151. doi:10.1016/j.canlet.2019.06.018
15.Fang J, Hong H, Xue X, et al. A novel circular RNA, circFAT1(e2), inhibits gastric cancer progression by targeting miR-548g in the cytoplasm and interacting with YBX1 in the nucleus. Cancer Lett. 2019;442:222‐232. doi:10.1016/j.canlet.2018.10.040
16.Conn SJ, Pillman KA, Toubia J, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160(6):1125–1134. doi:10.1016/j.cell.2015.02.014
17.Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell. 2011;146(3):353–358. doi:10.1016/j.cell.2011.07.014
18.Wesselhoeft RA, Kowalski PS, Anderson DG. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat Commun. 2018;9(1):2629. Published 2018 Jul 6. doi:10.1038/s41467-018-05096-6
19.Yang L, Venneti S, Nagrath D. Glutaminolysis: A Hallmark of Cancer Metabolism. Annu Rev Biomed Eng. 2017;19:163–194. doi:10.1146/annurev-bioeng-071516-044546
20.Cai J, Chen Z, Wang J, et al. circHECTD1 facilitates glutaminolysis to promote gastric cancer progression by targeting miR-1256 and activating β-catenin/c-Myc signaling. Cell Death Dis. 2019;10(8):576. Published 2019 Aug 2. doi:10.1038/s41419-019-1814-8
21.Zhen N, Gu S, Ma J, et al. CircHMGCS1 Promotes Hepatoblastoma Cell Proliferation by Regulating the IGF Signaling Pathway and Glutaminolysis. Theranostics. 2019;9(3):900‐919. Published 2019 Jan 25. doi:10.7150/thno.29515
22.Jin L, Alesi GN, Kang S. Glutaminolysis as a target for cancer therapy. Oncogene. 2016;35(28):3619–3625. doi:10.1038/onc.2015.447
23.Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12(12):931–947. doi:10.1038/nrd4002
24.Harris IS, Treloar AE, Inoue S, et al. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression [published correction appears in Cancer Cell. 2015 Feb 9;27(2):314]. Cancer Cell. 2015;27(2):211–222. doi:10.1016/j.ccell.2014.11.019
25.Wang S, Zhang X, Li Z, et al. Circular RNA profile identifies circOSBPL10 as an oncogenic factor and prognostic marker in gastric cancer. Oncogene. 2019;38(44):6985–7001. doi:10.1038/s41388-019-0933-0
26.Bleijs M, van de Wetering M, Clevers H, Drost J. Xenograft and organoid model systems in cancer research. EMBO J. 2019;38(15):e101654. doi:10.15252/embj.2019101654
27.Drost J, Clevers H. Organoids in cancer research. Nat Rev Cancer. 2018;18(7):407–418. doi:10.1038/s41568-018-0007-6
28.Xu H, Lyu X, Yi M, Zhao W, Song Y, Wu K. Organoid technology and applications in cancer research. J Hematol Oncol. 2018;11(1):116. Published 2018 Sep 15. doi:10.1186/s13045-018-0662-9
29.Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009;28(1-2):15–33. doi:10.1007/s10555-008-9169-0
30.Yeung KT, Yang J. Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol. 2017;11(1):28–39. doi:10.1002/1878-0261.12017
31.Huang R, Zong X. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression. Crit Rev Oncol Hematol. 2017;115:13–22. doi:10.1016/j.critrevonc.2017.04.005
32.Zhang Z, Wang J, Dong X. Wnt2 contributes to the progression of gastric cancer by promoting cell migration and invasion. Oncol Lett. 2018;16(3):2857–2864. doi:10.3892/ol.2018.9050
33.Katoh M. Frequent up-regulation of WNT2 in primary gastric cancer and colorectal cancer. Int J Oncol. 2001;19(5):1003–1007. doi:10.3892/ijo.19.5.1003
34.Katoh M. WNT2 and human gastrointestinal cancer (review). Int J Mol Med. 2003;12(5):811–816.
35.Li B, Cao Y, Meng G, et al. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway. EBioMedicine. 2019;39:239–254. doi:10.1016/j.ebiom.2018.11.063
36.Zhang J, Mao S, Guo Y, Wu Y, Yao X, Huang Y. Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer. Biosci Rep. 2019;39(6):BSR20181826. Published 2019 Jun 25. doi:10.1042/BSR20181826
37.Ebbesen KK, Kjems J, Hansen TB. Circular RNAs: Identification, biogenesis and function. Biochim Biophys Acta. 2016;1859(1):163–168. doi:10.1016/j.bbagrm.2015.07.007
38.Li X, Yang L, Chen LL. The Biogenesis, Functions, and Challenges of Circular RNAs. Mol Cell. 2018;71(3):428–442. doi:10.1016/j.molcel.2018.06.034
39.Fei T, Chen Y, Xiao T, et al. Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. Proc Natl Acad Sci U S A. 2017;114(26):E5207–E5215. doi:10.1073/pnas.1617467114
40.Zhang X, Wang S, Wang H, et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. Mol Cancer. 2019;18(1):20. Published 2019 Feb 4. doi:10.1186/s12943-018-0935-5
41.Zheng X, Huang M, Xing L, et al. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Mol Cancer. 2020;19(1):73. Published 2020 Apr 7. doi:10.1186/s12943-020-01183-9
42.Unterleuthner D, Neuhold P, Schwarz K, et al. Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer [published online ahead of print, 2019 Oct 30]. Angiogenesis. 2019;10.1007/s10456-019-09688-8. doi:10.1007/s10456-019-09688-8
43.Zhou Y, Huang Y, Cao X, et al. WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition. PLoS One. 2016;11(8):e0160414. Published 2016 Aug 11. doi:10.1371/journal.pone.0160414
44.Jiang H, Li Q, He C, et al. Activation of the Wnt pathway through Wnt2 promotes metastasis in pancreatic cancer. Am J Cancer Res. 2014;4(5):537–544. Published 2014 Sep 6.
45.Cheng XX, Wang ZC, Chen XY, et al. Correlation of Wnt-2 expression and beta-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination. Cancer Lett. 2005;223(2):339–347. doi:10.1016/j.canlet.2004.11.013
46.Molaei F, Forghanifard MM, Fahim Y, Abbaszadegan MR. Molecular Signaling in Tumorigenesis of Gastric Cancer. Iran Biomed J. 2018;22(4):217–230. doi:10.22034/ibj.22.4.217
47.Oliveira LA, Oshima CTF, Soffner PA, et al. THE CANONICAL WNT PATHWAY IN GASTRIC CARCINOMA. Arq Bras Cir Dig. 2019;32(1):e1414. Published 2019 Jan 7. doi:10.1590/0102-672020180001e1414
48.Sang Y, Chen B, Song X, et al. circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer. Mol Ther. 2019;27(9):1638–1652. doi:10.1016/j.ymthe.2019.05.011
49.Huang X, Li Z, Zhang Q, et al. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression. Mol Cancer. 2019;18(1):71. Published 2019 Mar 30. doi:10.1186/s12943-019-0969-3
50.Li Q, Pan X, Zhu D, Deng Z, Jiang R, Wang X. Circular RNA MAT2B Promotes Glycolysis and Malignancy of Hepatocellular Carcinoma Through the miR-338-3p/PKM2 Axis Under Hypoxic Stress. Hepatology. 2019;70(4):1298–1316. doi:10.1002/hep.30671
51.Wang Y, Wang F, He J, et al. miR-30a-3p Targets MAD2L1 and Regulates Proliferation of Gastric Cancer Cells. Onco Targets Ther. 2019;12:11313‐11324. Published 2019 Dec 19. doi:10.2147/OTT.S222854
52.Liu X, Ji Q, Zhang C, et al. miR-30a acts as a tumor suppressor by double-targeting COX-2 and BCL9 in H. pylori gastric cancer models. Sci Rep. 2017;7(1):7113. Published 2017 Aug 2. doi:10.1038/s41598-017-07193-w
53.Li D, Yang M, Liao A, et al. Linc00483 as ceRNA regulates proliferation and apoptosis through activating MAPKs in gastric cancer [published online ahead of print, 2018 May 15]. J Cell Mol Med. 2018;22(8):3875‐3886. doi:10.1111/jcmm.13661
54.Altman BJ, Stine ZE, Dang CV. From Krebs to clinic: glutamine metabolism to cancer therapy [published correction appears in Nat Rev Cancer. 2016 Dec;16(12 ):773] [published correction appears in Nat Rev Cancer. 2016 Nov;16(11):749]. Nat Rev Cancer. 2016;16(10):619‐634. doi:10.1038/nrc.2016.71
55.Lee N, Kim D. Cancer Metabolism: Fueling More than Just Growth. Mol Cells. 2016;39(12):847‐854. doi:10.14348/molcells.2016.0310
56.Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. 2010;35(8):427‐433. doi:10.1016/j.tibs.2010.05.003
57.Young VR, Ajami AM. Glutamine: the emperor or his clothes?. J Nutr. 2001;131(9 Suppl):2449S‐7S. doi:10.1093/jn/131.9.2449S
58.Durán RV, Oppliger W, Robitaille AM, et al. Glutaminolysis activates Rag-mTORC1 signaling. Mol Cell. 2012;47(3):349‐358. doi:10.1016/j.molcel.2012.05.043
59.Qing G, Li B, Vu A, et al. ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. Cancer Cell. 2012;22(5):631‐644. doi:10.1016/j.ccr.2012.09.021
60.Eng CH, Yu K, Lucas J, White E, Abraham RT. Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci Signal. 2010;3(119):ra31. Published 2010 Apr 27. doi:10.1126/scisignal.2000911